ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,350Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 69

$487K Total Retail Price of All Prescriptions

Rank: 12 out of 69

423 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 416 322 1 2
HYDROCODONE-ACETAMINOPHEN 320 204 S3 2 1
OMEPRAZOLE 307 246 3 8
AMLODIPINE BESYLATE 267 234 4 6
LEVOTHYROXINE SODIUM 262 208 5 7
METOPROLOL TARTRATE 211 173 6 5
METOPROLOL SUCCINATE 203 151 7 10
WARFARIN SODIUM 203 183 7 9
FUROSEMIDE 173 159 9 3
LISINOPRIL 161 138 10 4
ATENOLOL 151 138 11 11
DONEPEZIL HCL 146 145 12 42
ZOLPIDEM TARTRATE 143 113 13 26
ATORVASTATIN CALCIUM 140 121 14 14
MELOXICAM 136 96 15 33
BENAZEPRIL-HYDROCHLOROTHIAZIDE 131 100 16 171
METFORMIN HCL 121 88 17 12
NEXIUM 119 86 18 24
BENAZEPRIL HCL 115 103 19 148
HYDROCHLOROTHIAZIDE 113 92 20 22
CRESTOR 110 97 21 16
GLIPIZIDE ER 105 97 22 102
PANTOPRAZOLE SODIUM 100 90 23 56
CLONIDINE HCL 93 75 24 34
METFORMIN HCL ER 92 72 25 127
CLOPIDOGREL 89 58 26 17
NAMENDA 89 86 26 92
POTASSIUM CHLORIDE 87 67 28 21
PLAVIX 81 54 29 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 62 30 50
EVISTA 78 78 31 214
SERTRALINE HCL 78 77 31 58
LOSARTAN POTASSIUM 70 59 33 30
FELODIPINE ER 68 57 34 97
CITALOPRAM HBR 68 45 34 41
GABAPENTIN 66 46 36 15
TRIAMTERENE-HCTZ 62 62 37 67
PROAIR HFA 60 36 38 39
SYNTHROID 60 45 38 83
KLOR-CON M20 56 50 40 36
ALENDRONATE SODIUM 55 54 41 140
ROPINIROLE HCL 53 34 42 70
ISOSORBIDE MONONITRATE ER 52 51 43 20
ZETIA 51 34 44 49
LOVASTATIN 50 47 45 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.